Download
fgene-12-716132.pdf 2,05MB
WeightNameValue
1000 Titel
  • Predicting Protein Therapeutic Candidates for Bovine Babesiosis Using Secondary Structure Properties and Machine Learning
1000 Autor/in
  1. Goodswen, Stephen J. |
  2. Kennedy, Paul J. |
  3. Ellis, John T. |
1000 Verlag
  • Frontiers Media S.A.
1000 Erscheinungsjahr 2021
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2021-07-23
1000 Erschienen in
1000 Quellenangabe
  • 12:716132
1000 Copyrightjahr
  • 2021
1000 Embargo
  • 2022-01-25
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.3389/fgene.2021.716132 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8343536/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Abstract/Summary
  • <jats:p>Bovine babesiosis causes significant annual global economic loss in the beef and dairy cattle industry. It is a disease instigated from infection of red blood cells by haemoprotozoan parasites of the genus <jats:italic>Babesia</jats:italic> in the phylum Apicomplexa. Principal species are <jats:italic>Babesia bovis, Babesia bigemina</jats:italic>, and <jats:italic>Babesia divergens.</jats:italic> There is no subunit vaccine. Potential therapeutic targets against babesiosis include members of the exportome. This study investigates the novel use of protein secondary structure characteristics and machine learning algorithms to predict exportome membership probabilities. The premise of the approach is to detect characteristic differences that can help classify one protein type from another. Structural properties such as a protein’s local conformational classification states, backbone torsion angles ϕ (phi) and ψ (psi), solvent-accessible surface area, contact number, and half-sphere exposure are explored here as potential distinguishing protein characteristics. The presented methods that exploit these structural properties via machine learning are shown to have the capacity to detect exportome from non-exportome <jats:italic>Babesia bovis</jats:italic> proteins with an 86–92% accuracy (based on 10-fold cross validation and independent testing). These methods are encapsulated in freely available Linux pipelines setup for automated, high-throughput processing. Furthermore, proposed therapeutic candidates for laboratory investigation are provided for <jats:italic>B. bovis, B. bigemina</jats:italic>, and two other haemoprotozoan species, <jats:italic>Babesia canis</jats:italic>, and <jats:italic>Plasmodium falciparum.</jats:italic></jats:p>
1000 Sacherschließung
lokal machine learning
lokal protein secondary structure
lokal Genetics
lokal exportome
lokal vaccine
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/R29vZHN3ZW4sIFN0ZXBoZW4gSi4=|https://frl.publisso.de/adhoc/uri/S2VubmVkeSwgUGF1bCBKLg==|https://frl.publisso.de/adhoc/uri/RWxsaXMsIEpvaG4gVC4=
1000 Hinweis
  • DeepGreen-ID: a8cef34e8d5d41ae80b907e92fc5d5c0 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Förderer
  1. Australian Research Council |
1000 Fördernummer
  1. -
1000 Förderprogramm
  1. -
1000 Dateien
1000 Förderung
  1. 1000 joinedFunding-child
    1000 Förderer Australian Research Council |
    1000 Förderprogramm -
    1000 Fördernummer -
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6477982.rdf
1000 Erstellt am 2024-05-21T12:14:32.569+0200
1000 Erstellt von 322
1000 beschreibt frl:6477982
1000 Zuletzt bearbeitet 2024-05-22T09:37:29.697+0200
1000 Objekt bearb. Wed May 22 09:37:29 CEST 2024
1000 Vgl. frl:6477982
1000 Oai Id
  1. oai:frl.publisso.de:frl:6477982 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source